Francis P. Worden, MD, on the Role of Induction Chemotherapy in Laryngeal Preservation

March 02, 2020 By The ASCO Post Staff

Francis P. Worden, MD, of the University of Michigan Health System Comprehensive Cancer Center, explores the use of novel biomarkers that may help predict response to induction chemotherapy and survival in patients with locally advanced laryngeal cancer.

Related Content